Skip to content

Monoclonal Antibody 7C10-C5 Specific for the Novel Cancer Biomarker Methyl-Protein Phosphatase 2A

7C10-C5 can be used to assess methyl-PP2A levels in cancer tissue to diagnose the stage and subtype of disease

Published: 4th April 2022
Monoclonal Antibody 7C10-C5 Specific for the Novel Cancer Biomarker Methyl-Protein Phosphatase 2A
Header image is purely illustrative. Source: chokniti, stock.adobe.com/uk/266438665
Patents
  • Patent Application: WO2021148681A1
IP Status
  • Patent application submitted